Seeking Alpha

More on CVS Caremark (CVS): Retail pharmacy sales rose 4.3% with higher drug costs and the...

More on CVS Caremark (CVS): Retail pharmacy sales rose 4.3% with higher drug costs and the growth of the firm's Medicare Part D program contributing. The company raises and narrows its full-year guidance to $3.38-$3.41, from a prior range of $3.32-$3.38. (PR)

Check out Seeking Alpha’s new Earnings Center »

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs